Abstract:Abstract Background Currently, standard test kits based on the immunochromatography principle use 40 nm gold colloids as the labeling material. However, some kits use enzymes such as horseradish peroxidase and alkaline phosphatase (ALP) to improve sensitivity. Among the various labeling substances, 150 nm gold colloidal nanoparticles are thought to enable higher sensitivity in immunochromatography than the commonly used 40 nm gold colloids. This study aims to compare a detection method using 150 nm gold colloidal nanoparticles as a labeling material with a colorimetric detection method using ALP-labeled antibodies, which was previously studied in our laboratory. Methods 1) Detection method using 150 nm gold colloidal nanoparticlesThe BioReady high sensitivity gold conjugation kit for lateral flow (nanoComposix) was used to prepare gold colloid-labeled antibodies. Solid-phase antibodies, such as anti-human albumin monoclonal antibody (abcam) or anti-human troponin I monoclonal antibody (Merck Millipore), were applied onto a nitrocellulose membrane (HF075, Merck Millipore) and then transferred onto a test plate. The sample (human serum albumin or troponin I standard) was diluted with phosphate-buffered saline (PBS), and the gold colloid-labeled antibody and blocking solution (EzBlock Chemi, ATTO) were added and mixed. The mixture was added dropwise onto the test plate and incubated for 15 min. Subsequently, the results were recorded. 2) Chromogenic detection using ALP-conjugated antibodiesThis method was performed according to a method previously investigated in our laboratory. An anti-human albumin polyclonal antibody (DAKO) was applied onto a nitrocellulose membrane and then transferred onto a test plate. The membrane was mixed with the PBS-diluted sample, ALP-labeled anti-human albumin monoclonal antibody, and blocking solution. The mixture was added dropwise onto the test plate and incubated for 5 min. Subsequently, a drop of the chromogenic reagent was added directly onto the test plate, and the results were recorded after 10 min. Results Based on the immunochromatography results using 150 nm gold colloidal nanoparticles, black lines were detected in the judgment zone at albumin concentrations of 100, 10, and 3 ng/mL. Moreover, albumin concentrations of up to 3 ng/mL were detectable. Subsequently, the colorimetric detection results using ALP-labeled antibodies indicated that albumin concentrations of up to 100 ng/mL were detectable, with the exception of the 10 ng/mL concentration. Similarly, when troponin I was analyzed using 150 nm gold colloidal nanoparticles, black lines were detected in the judgment zone at troponin I concentrations of 30, 10, and 5 pg/mL. Conclusion In this study, the application of troponin I in point of care testing (POCT) was evaluated, indicating that troponin I was detectable at concentrations of up to 5 pg/mL. Because the detection sensitivity of commercially available immunochromatographic kits for troponin I is approximately 30 pg/mL, the developed method is six times more sensitive. Moreover, the developed method was demonstrated to be more sensitive than the chromogenic method using ALP-labeled antibodies.

Comparison and Development of Two Different Solid Phase Chemiluminescence ELISA for the Determination of Albumin in Urine

Performance evaluation of nine commonly used urine albumin assay systems

Development and comparison of two competitive ELISAs for the detection of bisphenol A in human urine

Comparison of Different Methods for Measurement of Microalbuminuria

Performance evaluation of different albumin assays for the detection of analbuminemia

Comparison of Chemiluminescence Enzyme Immunoassay Based on Magnetic Microparticles with Traditional Colorimetric ELISA for the Detection of Serum Α-Fetoprotein.

A-353 Investigation of the Immunochromatographic Method using 150 nm Gold Colloids (2)-Comparison with the ALP-based Chromogenic Detection Method

Quantification of Human Serum Albumin by Highly Sensitive Chemiluminescence Method

Chemiluminescence Method For The Determination Of Human Serum Albumin By Highly Sensitive Chemiluminescence Probe-Fluoresceinyl Cypridina Luciferin Analog

One-Step, Lateral-Flow Quantification of Human Urine Albumin Using an In-situ Minipump and Clinical Evaluation in Renal Patients

Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases

Establishment of ELISA Method and Distribution of Urinary Micro-Albumin in Normal People

Studies on an Immunosensor of Albumin Based on Surface Plasmon Resonance

Determination of Albumin Using the Chemiluminescence of Tb3+/K2S2O8System

Microalbuminuria sensitive near‐infrared AIE probe for point‐of‐care evaluating kidney diseases

Enzyme-Linked Immunosorbent Assay versus Chemiluminescent Immunoassay: A General Overview

Sensitive and accurate monitoring of urinary albumin and point-of-care testing using a fluorescent probe with anti-interference capacity against exogenous drugs

The Performance of the Abbott I2000 for Measuring Serum Markers of Infectious Diseases

Microplate Chemiluminescence Enzyme Immunoassay For The Quantitative Analysis Of Free Prostate-Specific Antigen In Human Serum

Comparison of routine test kits of creatinine in human serum with reversed-phase high-pressure liquid chromatographic assay

Noncompetitive Immunoassays Using Protein G Affinity Capillary Chromatography and Capillary Electrophoresis with Laser-Induced Fluorescence Detection.